Adapting the drivers to the road: a new strategy for cancer evolution?
Drug Development Department (DITEP); University Paris Sud, Inserm Unit U981.
M
M
Touat
Department ofRadiation Oncology.
F
F
Dhermain
University Paris Sud, Inserm Unit U981; Department of Medical Oncology, Gustave Roussy, Villejuif.
F
F
André
AP-HP, Department of Neurology Mazarin, Pitié-Salpêtrière Hospital, Paris; University Sorbonne UPMC, Inserm Unit U1127, CNRS Unit UMR 7225, Brain & Spine Institute, Paris, France. Electronic address: marc.sanson@psl.aphp.fr.
M
M
Sanson
D002292:Carcinoma, Renal Cell / Q000235:genetics*; D019143:Evolution, Molecular; D018740:Genetic Heterogeneity; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics*; D010641:Phenotype